Yüklüyor......
Enzyme Polymorphism in Warfarin Dose Management After Pediatric Cardiac Surgery
BACKGROUND: Warfarin is an anticoagulant and is widely used for the prevention of thromboembolic events. Genetic variants of the enzymes that metabolize warfarin, i.e. cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1), contribute to differences in patients’ responses to various w...
Kaydedildi:
| Yayımlandı: | Res Cardiovasc Med |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Kowsar
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592525/ https://ncbi.nlm.nih.gov/pubmed/26448196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/cardiovascmed.27963v2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|